Rollisid
Rollisid is a synthetic opioid analgesic developed by the pharmaceutical company Janssen Pharmaceuticals, Inc. It is a mu-opioid receptor agonist, meaning it binds to the same receptors in the brain as natural opioids like morphine, producing pain relief. Rollisid is available in tablet form and is typically prescribed for the management of moderate to severe chronic pain.
The drug is known for its rapid onset of action, with pain relief often occurring within 15
Like other opioids, rollisid carries a risk of dependence and abuse. It is important for patients to
Rollisid is not approved for use in all countries, and its availability may vary depending on regulatory